SE8107700L - Ylid-foreningar - Google Patents
Ylid-foreningarInfo
- Publication number
- SE8107700L SE8107700L SE8107700A SE8107700A SE8107700L SE 8107700 L SE8107700 L SE 8107700L SE 8107700 A SE8107700 A SE 8107700A SE 8107700 A SE8107700 A SE 8107700A SE 8107700 L SE8107700 L SE 8107700L
- Authority
- SE
- Sweden
- Prior art keywords
- compounds
- group
- denotes
- carbon atom
- van
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract 4
- 125000006239 protecting group Chemical group 0.000 claims abstract 4
- 229910052799 carbon Inorganic materials 0.000 claims abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract 3
- 125000002252 acyl group Chemical group 0.000 claims 1
- 125000002619 bicyclic group Chemical group 0.000 claims 1
- 150000001768 cations Chemical class 0.000 claims 1
- -1 phosphonio group Chemical group 0.000 claims 1
- 125000001476 phosphono group Chemical group [H]OP(*)(=O)O[H] 0.000 claims 1
- 238000012549 training Methods 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- MKYZBNHNPLKBNG-SDMSXHDGSA-N (5r)-6-amino-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical class S1C=C(C(O)=O)N2C(=O)C(N)[C@H]21 MKYZBNHNPLKBNG-SDMSXHDGSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000013067 intermediate product Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
- C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/568—Four-membered rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Claims (1)
1. Ylid-fbrening till anvandning sdsom mellanprodukt vid framstallningen av terapeutiskt vardefulla bicykliska tia-azaftreningar,kannetecknad darav, att den har den all-manna formeln: 7 -6" R3--R3 Cr.) 7--XA van ibetecknar en aminoskyddsgrupp ochbetecknar vate eller en acylgrupp Ac, eller van i 4 och 111.,) tillsammans bildar en tvdyard aminoskyddsgrupp, 4 betecknar en grupp, sea tillsammans med karboxylgrupperingenbildar en skyddad karboxylgrupp, och R3 betecknar vate eller en organisk grupp, torn Hr forbunden med ringkolatomen Byer en kolatom, och van i 0 antingen betecknar en trefaldigt substituerad fosfoniogrupp eller tvafaldigt fdrestrad fosfonogrupp tillsammans mod en katjon. RA
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1591475A CH620444A5 (en) | 1975-12-08 | 1975-12-08 | Process for the preparation of bicyclic unsaturated thiaaza compounds |
CH825276 | 1976-06-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE8107700L true SE8107700L (sv) | 1981-12-22 |
Family
ID=25703037
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8107701A SE8107701L (sv) | 1975-12-08 | 1981-12-22 | Alfa-ketokarboxylsyraforeningar |
SE8107700A SE8107700L (sv) | 1975-12-08 | 1981-12-22 | Ylid-foreningar |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8107701A SE8107701L (sv) | 1975-12-08 | 1981-12-22 | Alfa-ketokarboxylsyraforeningar |
Country Status (8)
Country | Link |
---|---|
US (1) | US4070477A (sv) |
JP (1) | JPS5271460A (sv) |
DE (1) | DE2655298A1 (sv) |
DK (1) | DK548076A (sv) |
FR (1) | FR2342730A1 (sv) |
GB (2) | GB1557559A (sv) |
NL (1) | NL7613663A (sv) |
SE (2) | SE8107701L (sv) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1543048A (en) * | 1976-02-04 | 1979-03-28 | Beecham Group Ltd | 4-mercapto-3-phenoxyacetamido-2-azetidinone |
JPS5398951A (en) * | 1977-02-08 | 1978-08-29 | Shionogi & Co Ltd | Azetidinone derivatives and process for their preparation |
LU77306A1 (sv) * | 1977-05-09 | 1979-01-18 | ||
EP0000636A1 (en) * | 1977-07-13 | 1979-02-07 | Glaxo Group Limited | Penem compounds, processes for their preparation, their use in pharmaceutical compositions and azetidinones used in their preparation |
US4168314A (en) * | 1977-11-17 | 1979-09-18 | Merck & Co., Inc. | 6-(1'-Hydroxyethyl)-2-aminoethylthio-pen-2-em-3-carboxylic acid |
US4169833A (en) * | 1977-12-14 | 1979-10-02 | Bristol-Myers Company | Novel phosphorane intermediates for use in preparing penem antibiotics |
US4192801A (en) * | 1978-04-27 | 1980-03-11 | Bristol-Myers Company | Novel phosphorane intermediates for use in preparing penem antibiotics |
US4264597A (en) * | 1978-06-06 | 1981-04-28 | Masashi Hashimoto | Cephalosporin analogues and processes for the preparation thereof |
NZ190994A (en) | 1978-07-24 | 1981-10-19 | Merck & Co Inc | Z-2-acylamino-3-monosubstituted propenoates |
US4880793A (en) * | 1978-07-24 | 1989-11-14 | Merck & Co., Inc. | Combination of thienamycin-type antibiotics with dipeptidase inhibitors |
JPS5625110A (en) * | 1978-12-18 | 1981-03-10 | Bristol Myers Co | Antibacterial |
US4339449A (en) * | 1979-03-27 | 1982-07-13 | Fujisawa Pharmaceutical Company, Limited | Analogous compounds of cephalosporins, and pharmaceutical composition comprising the same |
US4374065A (en) * | 1979-09-21 | 1983-02-15 | Bristol-Myers Company | Antibacterial agents of the β-lactam type |
US4378314A (en) * | 1979-09-21 | 1983-03-29 | Bristol Myers Company | Antibacterial agents and metal containing azetidinone intermediates therefore |
US4406834A (en) * | 1979-09-21 | 1983-09-27 | Bristol-Myers Company | 2,6 Disubstituted penems and intermediates therefor |
JPS59101485A (ja) * | 1982-11-29 | 1984-06-12 | Otsuka Chem Co Ltd | アセチジノン誘導体 |
US5288888A (en) * | 1993-04-28 | 1994-02-22 | American Cyanamid Company | Process for the synthesis of acetic acid, (dimethoxyphosphinyl) [[1,1-dimethylethyl)dimethylsilyl]-oxy]-, (4-nitrophenyl) methyl ester |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3778432A (en) * | 1971-12-13 | 1973-12-11 | Merck & Co Inc | Isocyanates and carbamates of penicillins and 3-cephem-4-carboxylic acids |
-
1976
- 1976-12-02 US US05/746,979 patent/US4070477A/en not_active Expired - Lifetime
- 1976-12-06 FR FR7636675A patent/FR2342730A1/fr active Granted
- 1976-12-06 GB GB50736/76A patent/GB1557559A/en not_active Expired
- 1976-12-06 GB GB13654/79A patent/GB1571177A/en not_active Expired
- 1976-12-07 DE DE19762655298 patent/DE2655298A1/de not_active Withdrawn
- 1976-12-07 DK DK548076A patent/DK548076A/da not_active Application Discontinuation
- 1976-12-08 NL NL7613663A patent/NL7613663A/xx not_active Application Discontinuation
- 1976-12-08 JP JP51146690A patent/JPS5271460A/ja active Pending
-
1981
- 1981-12-22 SE SE8107701A patent/SE8107701L/sv not_active Application Discontinuation
- 1981-12-22 SE SE8107700A patent/SE8107700L/sv not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SE8107701L (sv) | 1981-12-22 |
DK548076A (da) | 1977-06-09 |
FR2342730A1 (fr) | 1977-09-30 |
DE2655298A1 (de) | 1977-06-23 |
US4070477A (en) | 1978-01-24 |
FR2342730B1 (sv) | 1982-11-26 |
JPS5271460A (en) | 1977-06-14 |
NL7613663A (nl) | 1977-06-10 |
GB1571177A (en) | 1980-07-09 |
GB1557559A (en) | 1979-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8107700L (sv) | Ylid-foreningar | |
CA2054619A1 (en) | Aminocoumaran derivatives, their production and use | |
AR003936A1 (es) | Compuestos triciclicos y composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de un medicamento util para inhibir elcrecimiento anormal de celulas. | |
AT380252B (de) | Verfahren zur herstellung von neuen guanin- und 2,6-diaminopurinderivaten und ihren salzen | |
IE37767B1 (en) | Derivatives of 7beta-amino-cephem-3-ol-4-carboxylic acids | |
ES474215A1 (es) | Procedimiento para la preparacion de derivados imidazolile- tiloxialcoxilicos y sus analogos con agrupacion tio | |
ATE142641T1 (de) | Neue peptid-verbindungen und verfahren zur herstellung davon | |
ATE150747T1 (de) | Indolderivate | |
IE35709B1 (en) | 8-oxo-5-thia-1-azabi-cyclo(4,2,0)oct-2-ene compounds,process for their manufacture and compositions containing them | |
ATE61340T1 (de) | Aminosaeurederivate und deren verfahren zur herstellung. | |
SE8107273L (sv) | 2-oxoazetidinderivat, sett att framstella democh anvendning derav | |
SE8101464L (sv) | 2-penem-3-karboxylsyraderivat, deras framstellning och anvendning | |
SE7907672L (sv) | Mellanprodukter for framstellning av farmaceutiskt verdefulla cefalosporinforeningar | |
IL64647A (en) | 2,8-disubstituted-4-thiomorpholino-pyrimido(5,4-d)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them | |
DK0408760T3 (da) | Hydroxylaminderivater | |
IE781144L (en) | Amido penicillanic acids | |
SE7609909L (sv) | Nya penicilliner och forfarande for framstellning derav | |
HUP0204217A2 (en) | Novel a-500359 derivatives | |
ATE42295T1 (de) | Penem-derivate, verfahren zu deren herstellung, ihre verwendung und pharmazeutische zusammensetzungen. | |
ES499912A1 (es) | Procedimiento para la obtencion de derivados de amino-tia- diazolilo | |
ES8507506A1 (es) | Procedimiento para la obtencion de derivados de diaril-imidazol. | |
ATE32724T1 (de) | Cephalosporinverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
ES8101646A1 (es) | Un procedimiento para producir un compuesto opticamente ac- tivo | |
ATE58129T1 (de) | Dem antibiotikum tan-749 aehnliche verbindungen und ihre herstellung. | |
ATE146463T1 (de) | Säureanhydride, ihre herstellung und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |
Ref document number: 8107700-0 Format of ref document f/p: F |